Study
Cranberry Capsules May Reduce UTIs in High-Risk Seniors
Taking cranberry capsules twice daily reduced urinary tract infections by nearly 26% in high-risk seniors living in care facilities.
Summary
In plain language
New research suggests that cranberry capsules can help reduce urinary tract infections (UTIs) in seniors living in long-term care facilities who are at high risk. The study involved 928 participants, mostly women with a median age of 84. Those with a higher risk of UTIs, such as individuals with diabetes or previous infections, saw a significant reduction in clinically defined UTIs when taking cranberry capsules compared to a placebo. However, there was no impact on those at lower risk. This finding is important as it offers a potential natural way to manage UTIs, especially for seniors who might be wary of antibiotics. It's always best to discuss any new supplement with your healthcare provider.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study was a carefully controlled trial involving over 900 seniors in long-term care facilities. Participants were randomly assigned to receive either cranberry capsules or a placebo for a year, with the goal of assessing the capsules' effectiveness in preventing UTIs.
The study found that among high-risk seniors, those taking cranberry capsules experienced a 26% reduction in clinically defined UTIs compared to those taking a placebo.
The study did not show a reduction in UTIs when using a stricter definition of the infection, nor did it find benefits for those at lower UTI risk.
While the study shows promise, it is important to remember that cranberry capsules didn't affect all types of UTIs and are not a substitute for medical advice.
Discuss with your healthcare provider if cranberry capsules might be helpful for your situation.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Cranberry Capsules May Reduce UTIs in High-Risk Seniors
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 5, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored highly due to its rigorous design as a double-blind randomized controlled trial with comprehensive bias control measures. Statistical methods were robust, with pre-specified endpoints and adequate power. Transparency was ensured through pre-registration and detailed reporting. The study was relevant to the target population of older adults. However, no replication evidence was provided, and journal quality could not be assessed due to lack of information.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 10.0/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 10.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This study evaluates the effectiveness of cranberry capsules in preventing urinary tract infections (UTIs) in long-term care facility residents. It found a reduction in clinically defined UTIs in high-risk individuals but no effect on strictly defined UTIs.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.